PRIMARY GRAFT DYSFUNCTION
Clinical trials for PRIMARY GRAFT DYSFUNCTION explained in plain language.
Never miss a new study
Get alerted when new PRIMARY GRAFT DYSFUNCTION trials appear
Sign up with your email to follow new studies for PRIMARY GRAFT DYSFUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New device aims to reduce heart transplant complications
Disease control Recruiting nowThis study tests a new temperature control system (Xo Port) for preserving donor hearts during transplant, compared to the standard ice method. The goal is to see if it reduces severe complications like primary graft dysfunction. About 50 adult heart transplant recipients will ta…
Matched conditions: PRIMARY GRAFT DYSFUNCTION
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could an HIV drug protect new lungs after transplant?
Disease control Recruiting nowThis study tests whether Maraviroc, a drug already approved for HIV, can prevent a serious lung injury called primary graft dysfunction (PGD) after a lung transplant. PGD is a major cause of death in the first year after transplant, and there are no approved treatments for it. Ab…
Matched conditions: PRIMARY GRAFT DYSFUNCTION
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Blood markers may flag lung transplant danger — study investigates
Knowledge-focused Recruiting nowPrimary graft dysfunction (PGD) is a serious lung complication that can develop shortly after a lung transplant. This study looks at blood samples from people receiving a lung or combined heart-lung transplant to see whether high levels of certain chemicals are linked to a higher…
Matched conditions: PRIMARY GRAFT DYSFUNCTION
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC